The potential of signal transduction inhibitors for the treatment of arthritis: Is it all just JNK?
- PMID: 11457869
- PMCID: PMC203031
- DOI: 10.1172/JCI13508
The potential of signal transduction inhibitors for the treatment of arthritis: Is it all just JNK?
Figures
Comment on
-
c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis.J Clin Invest. 2001 Jul;108(1):73-81. doi: 10.1172/JCI12466. J Clin Invest. 2001. PMID: 11435459 Free PMC article.
References
-
- Ruddy, S., Harris, E.D., Sledge, C.B., and Kelley, W.N. 2001. Kelley’s textbook of rheumatology. W.B. Saunders Co. Philadelphia, Pennsylvania, USA. 1904 pp.
-
- Arend WP, Dayer JM. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheum. 1995;38:151–160. - PubMed
-
- Nagase H, Woessner JF., Jr Matrix metalloproteinases. J Biol Chem. 1999;274:21491–21494. - PubMed
-
- Vincenti MP. The matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase (TIMP) genes. Transcriptional and posttranscriptional regulation, signal transduction and cell-type-specific expression. Methods Mol Biol. 2001;151:121–148. - PubMed
-
- Auble DT, Brinckerhoff CE. The AP-1 sequence is necessary but not sufficient for phorbol induction of collagenase in fibroblasts. Biochemistry. 1991;30:4629–4635. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
